Alcohol-induced myocardial fibrosis in metallothionein-null mice: Prevention by zinc supplementation

American Journal of Pathology

Volumn 167, Issue 2, 2005, Pages 337-344

  Wang, Lipeng ^a   Zhou, Zhanxiang ^a   Saari, Jack T ^b   Kang, Y James ^a  

^a University of Louisville School of Medicine   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREATINE KINASE; METALLOTHIONEIN; ZINC;

ALCOHOLIC CARDIOMYOPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; HEART HYPERTROPHY; HEART INJURY; HEART MUSCLE FIBROSIS; HOMEOSTASIS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WILD TYPE; ANIMAL; DRUG EFFECT; FIBROSIS; GENETICS; HEART; HEART MUSCLE; HOMOZYGOTE; HYPERTROPHY; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CARDIOMYOPATHY, ALCOHOLIC; DIETARY SUPPLEMENTS; ETHANOL; FIBROSIS; HEART; HOMOZYGOTE; HYPERTROPHY; LIVER; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; MYOCARDIUM; ZINC;

EID: 85047692717     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62979-3     Document Type: Article

References (52)

1. Camps J, Bargallo T, Gimenez A, Alie S, Caballeria J, Pares A, Joven J, Masana L, Rodes J: Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration. Clin Sci (Lond) 1992, 83:695-700
2. Mezey E, Potter JJ, Maddrey WC: Hepatic collagen proline hydroxylase activity in alcoholic liver disease. Clin Chim Acta 1976, 68:313-320
3. Mann SW, Fuller GC, Rodil JV, Vidins EI: Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease. Gut 1979, 20:825-832
4. Anttinen H, Ryhanen L, Puistola U, Arranto A, Oikarinen A: Decrease in liver collagen accumulation in carbon tetrachloride-injured and normal growing rats upon administration of zinc. Gastroenterology 1984, 86:532-539
5. Cabre M, Camps J, Ferre N, Paternain JL, Joven J: The antioxidant and hepatoprotective effects of zinc are related to hepatic cytochrome P450 depression and metallothionein induction in rats with experimental cirrhosis. Int J Vitam Nutr Res 2001, 71:229-236
6. Gimenez A, Pares A, Alie S, Camps J, Deulofeu R, Caballeria J, Rodes J: Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol 1994, 21:292-298
7. McClain CJ, Su LC: Zinc deficiency in the alcoholic: a review. Alcohol Clin Exp Res 1983, 7:5-10
8. Topuzoglu G, Erbay AR, Karul AB, Yensel N: Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy. Biol Trace Elem Res 2003, 95:11-17
9. Martin-Lagos F, Navarro-Alarcon M, Terres-Martos C, Lopez G, de la Serrana H, Lopez-Martinez MC: Serum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease. Sci Total Environ 1997, 204:27-35
10. Oster O: Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta 1993, 214:209-218
11. Bogden JD, Al-Rabiai S, Gilani SH: Effect of chronic ethanol ingestion on the metabolism of copper, iron, manganese, selenium, and zinc in an animal model of alcoholic cardiomyopathy. J Toxicol Environ Health 1984, 14:407-417
12. McClain CJ, Antonow DR, Cohen DA, Shedlofsky SI: Zinc metabolism in alcoholic liver disease. Alcohol Clin Exp Res 1986, 10:582-589
13. Cook CC, Waiden RJ, Graham BR, Gillham C, Davies S, Prichard BN: Trace element and vitamin deficiency in alcoholic and control subjects. Alcohol Alcohol 1991, 26:541-548
14. Loguercio C, De Girolamo V, Federico A, Feng SL, Cataldi V, Del Vecchio Blanco C, Gialanella G: Trace elements and chronic liver diseases. J Trace Elem Med Biol 1997, 11:158-161
15. Kagi JH: Overview of metallothionein. Methods Enzymol 1991, 205:613-626
16. Maret W: The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 2000, 130(Suppl 5):1455S-1458S
17. Otvos JD, Armitage IM: Structure of the metal clusters in rabbit liver metallothionein. Proc Natl Acad Sci USA 1980, 77:7094-7098
18. Vallee BL: The function of metallothionein. Neurochem Int 1995, 27:23-33
19. Maret W, Vallee BL: Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 1998, 95:3478-3482
20. Maret W: Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc Natl Acad Sci USA 1994, 91:237-241
21. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD: Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 1994, 91:584-588
22. Habeebu SS, Liu J, Liu Y, Klaassen CD: Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium. Toxicol Sci 2000, 55:223-232
23. Liu J, Liu Y, Habeebu SS, Klaassen CD: Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol Appl Pharmacol 1998, 149:24-31
24. Nielsen FH, Zimmerman TJ, Shuler TR: Interactions among nickel, copper and iron in rats: liver and plasma contents of lipids and trace elements. Biol Trace Elem Res 1982, 4:125-143
25. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN: Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 1997, 100:1501-1506
26. Sun X, Zhou Z, Kang YJ: Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 2001, 61:3382-3387
27. Jiang Y, Kang YJ: Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Mol Ther 2004, 10:1130-1139
28. Klatsky AL: Alcohol and cardiovascular diseases: a historical overview. Novartis Found Symp 1998, 216:2-12
29. Fauchier L, Babuty D, Poret P, Casset-Senon D, Autret ML, Cosnay P, Fauchier JP: Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 2000, 21:306-314
30. McKenna CJ, Codd MB, McCann HA, Sugrue DD: Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J 1998, 135:833-837
31. Gavazzi A, De Maria R, Parolini M, Porcu M: Alcohol abuse and dilated cardiomyopathy in men. Am J Cardiol 2000, 85:1114-1118
32. Regan TJ: Alcohol and the cardiovascular system. JAMA 1990, 264:377-381
33. Lazarevic AM, Nakatani S, Neskovic AN, Marinkovic J, Yasumura Y, Stojicic D, Miyatake K, Bojic M, Popovic AD: Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol 2000, 35:1599-1606
34. Kupari M, Koskinen P, Suokas A, Ventila M: Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 1990, 66:1473-1477
35. Askanas A, Udoshi M, Sadjadi SA: The heart in chronic alcoholism: a noninvasive study. Am Heart J 1980, 99:9-16
36. Silberbauer K, Juhasz M, Ohrenberger G, Hess C: Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in young alcoholics. Cardiology 1988, 75:431-439
37. Mathews Jr EC, Gardin JM, Henry WL, Del Negro AA, Fletcher RD, Snow JA, Epstein SE: Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 1981, 47:570-578
38. Regan TJ, Morvai V: Experimental models for studying the effects of ethanol on the myocardium. Acta Med Scand Suppl 1987, 717:107-113
39. Capasso JM, Li P, Guideri G, Malhotra A, Cortese R, Anversa P: Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats. Circ Res 1992, 71:346-356
40. Chan TC, Sutter MC: The effects of chronic ethanol consumption on cardiac function in rats. Can J Physiol Pharmacol 1982, 60:777-782
41. Thomas AP, Rozanski DJ, Renard DC, Rubin E: Effects of ethanol on the contractile function of the heart: a review. Alcohol Clin Exp Res 1994, 18:121-131
42. Kim SD, Beck J, Bieniarz T, Schumacher A, Piano MR: A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography. Alcohol Clin Exp Res 2001, 25:457-463
43. Kim SD, Bieniarz T, Esser KA, Piano MR: Cardiac structure and function after short-term ethanol consumption in rats. Alcohol 2003, 29:21-29
44. Lowenstein SR, Weissberg MP, Terry D: Alcohol intoxication, injuries, and dangerous behaviors and the revolving emergency department door. J Trauma 1990, 30:1252-1258
45. Adachi J, Mizoi Y, Fukunaga T, Ogawa Y, Ueno Y, Imamichi H: Degrees of alcohol intoxication in 117 hospitalized cases. J Stud Alcohol 1991, 52:448-453
46. Brennan DF, Betzelos S, Reed R, Falk JL: Ethanol elimination rates in an ED population. Am J Emerg Med 1995, 13:276-280
47. St.Croix CM, Wasserloos KJ, Dineley KE, Reynolds IJ, Levitan ES, Pitt BR: Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am J Physiol 2002, 282:L185-L192
48. Kang YJ: The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 1999, 222:263-273
49. Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB: Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 2000, 275:13690-13698
50. Wang GW, Klein JB, Kang YJ: Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001, 298:461-468
51. Kang YJ, Li Y, Sun X, Sun X: Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. Am J Pathol 2003, 163:1579-1586
52. Sun X, Zhou Z, Kang YJ: Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 2001, 61:3382-3387